FDA Social Media Guides Draw Industry, User Criticism
Sunday, September 28, 2014
Source: Medical Marketing & Media
Two FDA guidance documents on how health product manufacturers may participate in social media have each drawn criticism from affected industry and consumer groups. Both documents, one on presenting risk/benefit information on Internet/social media platforms with space character limitations and the other on dealing with misinformation about products by third parties, were published in June.
Among comments on the character limitations draft guidance, the industry-funded Washington Legal Foundation (WLF) expressed “grave concerns” about several provisions in it.